CLINICAL-TRIALS OF TOPICAL INTERFERON THERAPY OF ULCERATIVE VIRAL KERATITIS

被引:24
|
作者
JONES, BR
COSTER, DJ
FALCON, MG
CANTELL, K
机构
[1] STATE SERUM INST,CENT PUBL HLTH LAB,DEPT VIROL,HELSINKI,FINLAND
[2] UNIV LONDON,MOORFIELDS EYE HOSP,INST OPHTHALMOL,DEPT CLIN OPHTHALMOL,LONDON EC1V 2PD,ENGLAND
来源
关键词
D O I
10.1093/infdis/133.Supplement_2.A169
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:A169 / A172
页数:4
相关论文
共 50 条
  • [31] TOPICAL CIPROFLOXACIN VERSUS CONVENTIONAL ANTIBIOTIC-THERAPY IN THE TREATMENT OF ULCERATIVE KERATITIS
    ABRAMS, DA
    SARFARAZI, FA
    PARKS, DJ
    KATZ, HR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 1171 - 1171
  • [32] COMPARISON OF TOPICAL CIPROFLOXACIN TO CONVENTIONAL ANTIBIOTIC-THERAPY IN THE TREATMENT OF ULCERATIVE KERATITIS
    PARKS, DJ
    ABRAMS, DA
    SARFARAZI, FA
    KATZ, HR
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1993, 115 (04) : 471 - 477
  • [33] CLINICAL-TRIALS WITH INTERFERON INDUCING DOUBLE-STRANDED-RNA
    BORECKY, L
    DOSKOCIL, J
    LACKOVIC, V
    BUCHVALD, V
    MALY, E
    GRUNTOVA, Z
    OBRUCNIKOVA, E
    OBRUCNIK, M
    ZUFFA, A
    HAVRANKOVA, M
    ACTA MICROBIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1977, 24 (01): : 77 - 77
  • [34] INTERFERON AS A BIOLOGICAL RESPONSE MODIFYING AGENT IN CLINICAL-TRIALS - INTRODUCTION
    SMALLEY, RV
    OLDHAM, RK
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1983, 2 (05): : 401 - 408
  • [35] MONITORING LATE EFFECTS OF THERAPY IN CLINICAL-TRIALS
    HERSON, J
    STRONG, LC
    CONTROLLED CLINICAL TRIALS, 1981, 2 (01): : 81 - 81
  • [36] CLINICAL-TRIALS UTILIZING PHOTODYNAMIC THERAPY FOR CANCER
    WALDOW, SM
    LOBRAICO, RV
    HARRIS, DM
    HILL, JH
    MUNOZ, M
    PYRCZ, RA
    KURUC, EA
    LASERS IN SURGERY AND MEDICINE, 1986, 6 (02) : 227 - 227
  • [37] IMMUNE INTERFERON FOR CLINICAL-TRIALS - CONDITIONS FOR INDUCTION, PURIFICATION, AND STABILITY
    PAPERMASTER, VM
    BARON, S
    TEXAS REPORTS ON BIOLOGY AND MEDICINE, 1982, 41 : 672 - 680
  • [38] CORTISOL INDUCTION BY POLY ICLC - IMPLICATIONS FOR CLINICAL-TRIALS OF INTERFERON
    BEVER, CT
    MCFARLAND, HF
    LEVY, HB
    MCFARLIN, DE
    ANNALS OF NEUROLOGY, 1988, 23 (02) : 196 - 199
  • [39] CLINICAL-TRIALS
    CARTER, SK
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1978, 3 (04) : 215 - 218
  • [40] CLINICAL-TRIALS
    HICKEY, T
    PROCEEDINGS OF THE ASIS ANNUAL MEETING, 1992, 29 : 350 - 350